Group One Trading
IRLA

Group One Trading’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Group One Trading’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-702
Closed -$141K – 8527
2025
Q4 		$471K Buy
702
+548
+356% +$276K ﹤0.01% 3581
2025
Q3 		$50.3K Buy
+154
New +$51.3K ﹤0.01% 5959
2025
Q2 		– Sell
-1
Closed -$229 – 8528
2025
Q1 		$327 Buy
+1
New +$305 ﹤0.01% 7336
2024
Q3 		– Sell
-8
Closed -$1.2K – 7236
2024
Q2 		$1.2K Hold
8
– – ﹤0.01% 6330
2024
Q1 		$1.7K Buy
+8
New +$1.99K ﹤0.01% 6522
2023
Q1 		– Sell
-204
Closed -$39.9K – 7815
2022
Q4 		$26K Sell
204
-481
-70% -$80.4K ﹤0.01% 5443
2022
Q3 		$182K Sell
685
-15
-2% -$5.71K ﹤0.01% 4236
2022
Q2 		$311K Buy
700
+178
+34% +$126K ﹤0.01% 3885
2022
Q1 		$647K Buy
+522
New +$710K ﹤0.01% 3538
2021
Q2 		– Sell
-18
Closed -$151K – 8498
2021
Q1 		$130K Buy
18
+15
+500% +$108K ﹤0.01% 5417
2020
Q4 		$14K Buy
+3
New +$26.6K ﹤0.01% 5670
2020
Q3 		– Hold
0
– – – 5941

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's IRLA Position: Q1 2026 in Review

Group One Trading sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2026, closing a stake of 702 shares — an estimated $141K sold.

Group One Trading first reported a position in IRLA in Q4 2020 and held it in 11 quarters. The position peaked at $647K in Q1 2022. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

  • Group One Trading reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 702 IRulya Therapeutics Inc. Common Stock shares in Q1 2026, an estimated $141K.
  • Group One Trading first reported a position in IRulya Therapeutics Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • Group One Trading's IRulya Therapeutics Inc. Common Stock position peaked at $647K in Q1 2022.
  • 43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.